Thousands of men with high-risk prostate cancer could soon live longer, thanks to a  test that helps doctors identify which ...

I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

Improvements in the PSA screening process make it worth another look.

Prostate cancer is one of the most common cancers affecting men worldwide, yet it remains surrounded by confusion, myths, and unanswered questions. Many men believe they only need to worry about ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Find Prostate Cancer Screening Latest News, Videos & Pictures on Prostate Cancer Screening and see latest updates, news, information from NDTV.COM. Explore more on Prostate Cancer Screening.